We are live on
!
Find out more
Corcept Therapeutics
CORT
CORT
62 hedge funds and large institutions have $102M invested in Corcept Therapeutics in 2014 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 21 increasing their positions, 19 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
264% more call options, than puts
Call options by funds: $91K | Put options by funds: $25K
30% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 10
11% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 19
5% more funds holding
Funds holding: 59 → 62 (+3)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
37% less capital invested
Capital invested by funds: $161M → $102M (-$59.1M)
Holders
62
Holders Change
+3
Holders Change %
+5.08%
% of All Funds
1.78%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
13
Increased
21
Reduced
19
Closed
10
Calls
$91K
Puts
$25K
Net Calls
+$66K
Net Calls Change
-$2.34M
Top Buyers
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$3.25M |
| 2 |
CCA
Catalyst Capital Advisors
Huntington,
New York
|
+$1.59M |
| 3 |
ISL
Ingalls & Snyder LLC
New York
|
+$459K |
| 4 |
Goldman Sachs
New York
|
+$400K |
| 5 |
State Street
Boston,
Massachusetts
|
+$328K |
Top Sellers
| 1 |
Jennison Associates
New York
|
-$9.38M |
| 2 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$1.04M |
| 3 |
Millennium Management
New York
|
-$443K |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$381K |
| 5 |
Barclays
London,
United Kingdom
|
-$335K |
